Latest filing published 11 Apr 2022 for T2 Biosystems, Inc., €5,960.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -13.4%Entry US$48.50 · Close at T+365 US$42.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alec Barclay: trading record in brief
Alec Barclay discloses dealings in T2 Biosystems, Inc. to SEC (Form 4). In total, 21 filings cover trades dated from 6 June 2018 to 8 April 2022.
The open-market side counts 1 purchase for €5,960 alongside 4 sales for €47k. Netting one side against the other leaves €41k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 7 share grants and 9 option exercises. 2022 to date brings 1 purchase and no sales.
On 11 April 2022 came the latest disclosure, an open-market purchase for €5,960 in T2 Biosystems, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alec Barclay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,951.88 shares@ US$0.50100.0% of flowCommon StockSEC:0000899243-22-014418:0Canonical exit: 7 Jul 2022 (T+90)
- 11,428 shares@ US$0.364Common StockSEC:0000899243-22-012779:1
- 21,666 sharesCommon StockSEC:0000899243-22-012779:0
- 88,878 shares@ US$0.4488Common StockSEC:0000899243-22-008057:1
- 168,488 sharesCommon StockSEC:0000899243-22-008057:0
- 5,275 shares@ US$0.466Common StockSEC:0000899243-22-007494:1
- 10,000 sharesCommon StockSEC:0000899243-22-007494:0
- 12,494 shares@ US$1.860.0% of flowCommon StockSEC:0000899243-21-012548:0
- 21,667 sharesCommon StockSEC:0000899243-21-011890:0
- 7,280 shares@ US$2.060.0% of flowCommon StockSEC:0000899243-21-007771:1
- 10,000 sharesCommon StockSEC:0000899243-21-007771:0
- 10,000 sharesCommon StockSEC:0000899243-20-005808:0
- 5,808 shares@ US$0.820.0% of flowCommon StockSEC:0000899243-20-005808:1
- 10,000 sharesCommon StockSEC:0000899243-19-023537:0
- 4,210 shares@ US$2.920.0% of flowCommon StockSEC:0000899243-19-023537:1
- 10,000 sharesCommon StockSEC:0000899243-18-024446:0
- 3,522 shares@ US$6.490.1% of flowCommon StockSEC:0000899243-18-024446:1
- 7,824 shares@ US$6.720.1% of flowCommon StockSEC:0000899243-18-020507:0
- 24,086 shares0Common StockSEC:0000899243-18-018684:0
- 13,583 shares0Common StockSEC:0000899243-18-015723:0
- 4,408 shares@ US$8.530.1% of flowCommon StockSEC:0000899243-18-015723:1
21 of 21 declarations